Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis.

De Luca C, Sgariglia R, Nacchio M, Pisapia P, Migliatico I, Clery E, Gragnano G, Campione S, Vigliar E, Malapelle U, De Dominicis G, Bellevicine C, Troncone G.

Diagn Cytopathol. 2020 Jan 6. doi: 10.1002/dc.24378. [Epub ahead of print]

PMID:
31904908
2.

Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.

Pepe F, Pisapia P, Del Basso de Caro ML, Conticelli F, Malapelle U, Troncone G, Martinez JC.

Histol Histopathol. 2019 Dec 24:18195. doi: 10.14670/HH-18-195. [Epub ahead of print]

PMID:
31872418
3.

Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.

Bellevicine C, Migliatico I, Sgariglia R, Nacchio M, Vigliar E, Pisapia P, Iaccarino A, Bruzzese D, Fonderico F, Salvatore D, Biondi B, Masone S, Novizio V, Scavuzzo F, Serino D, De Palma M, Chiofalo MG, Botti G, Pezzullo L, Nuzzo V, Spiezia S, De Chiara G, Iorio S, Conzo G, Docimo G, Faggiano A, Bongiovanni M, Malapelle U, Colao A, Triassi M, Troncone G; Tiroide Network.

Cancer Cytopathol. 2019 Dec 10. doi: 10.1002/cncy.22217. [Epub ahead of print]

PMID:
31821746
4.

EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing.

Lettig L, Sahnane N, Pepe F, Cerutti R, Albeni C, Franzi F, Veronesi G, Ogliari F, Pastore A, Tuzi A, Pinotti G, Bovio A, Verusio C, Giordano M, Troncone G, Sessa F, Malapelle U, Furlan D.

Transl Lung Cancer Res. 2019 Oct;8(5):584-592. doi: 10.21037/tlcr.2019.09.18.

5.

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions.

Villatoro S, Mayo-de-Las-Casas C, Jordana-Ariza N, Viteri-Ramírez S, Garzón-Ibañez M, Moya-Horno I, García-Peláez B, González-Cao M, Malapelle U, Balada-Bel A, Martínez-Bueno A, Campos R, Reguart N, Majem M, Blanco R, Blasco A, Catalán MJ, González X, Troncone G, Karachaliou N, Rosell R, Molina-Vila MA.

Mol Oncol. 2019 Dec;13(12):2633-2645. doi: 10.1002/1878-0261.12574. Epub 2019 Oct 11.

6.

Approach to cytological indeterminate thyroid nodules.

Bongiovanni M, Bellevicine C, Troncone G, Sykiotis GP.

Gland Surg. 2019 Aug;8(Suppl 2):S98-S104. doi: 10.21037/gs.2018.12.06. Review.

7.

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.

Bruera G, Massacese S, Pepe F, Malapelle U, Dal Mas A, Ciacco E, Calvisi G, Troncone G, Simmaco M, Ricevuto E.

Ther Adv Med Oncol. 2019 May 10;11:1758835919846421. doi: 10.1177/1758835919846421. eCollection 2019.

8.

Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018.

Pisapia P, Bellevicine C, Malapelle U, De Luca C, Vigliar E, Troncone G.

Cancer Cytopathol. 2019 May 28. doi: 10.1002/cncy.22118. [Epub ahead of print] Review.

PMID:
31135103
9.

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study.

De Luca C, Conticelli F, Leone A, Gragnano G, Salatiello M, Galasso P, Pisapia P, Grillo LR, Iaccarino A, Vigliar E, Bellevicine C, Malapelle U, Troncone G.

J Clin Pathol. 2019 Sep;72(9):609-614. doi: 10.1136/jclinpath-2019-205863. Epub 2019 May 20.

PMID:
31110050
10.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.

Pisapia P, Malapelle U, Roma G, Saddar S, Zheng Q, Pepe F, Bruzzese D, Vigliar E, Bellevicine C, Luthra R, Nikiforov YE, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Bihl M, Savic S, Bubendorf L, de Biase D, Tallini G, Hwang DH, Sholl LM, Vander Borght S, Weynand B, Stieber D, Vielh P, Rappa A, Barberis M, Fassan M, Rugge M, De Andrea CE, Lozano MD, Lupi C, Fontanini G, Schmitt F, Dumur CI, Bisig B, Bongiovanni M, Merkelbach-Bruse S, Büttner R, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2019 May;127(5):285-296. doi: 10.1002/cncy.22134. Epub 2019 Apr 25.

PMID:
31021538
11.

Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment.

Vigliar E, Pepe F, Migliatico I, Nacchio M, Cesaro S, Della Pepa R, Bellevicine C, Malapelle U, Fassan M, Pane F, Picardi M, Troncone G.

Diagn Cytopathol. 2019 Aug;47(8):749-757. doi: 10.1002/dc.24184. Epub 2019 Apr 5.

PMID:
30953406
12.

Role of Cytomorphology in the Era of Liquid Biopsy.

Clery E, Pisapia P, Vigliar E, Malapelle U, Bellevicine C, Troncone G, Schmitt FC.

Acta Cytol. 2019;63(6):497-505. doi: 10.1159/000499338. Epub 2019 Apr 3. Review.

PMID:
30943469
13.

Invited review-next-generation sequencing: a modern tool in cytopathology.

Roy-Chowdhuri S, Pisapia P, Salto-Tellez M, Savic S, Nacchio M, de Biase D, Tallini G, Troncone G, Schmitt F.

Virchows Arch. 2019 Jul;475(1):3-11. doi: 10.1007/s00428-019-02559-z. Epub 2019 Mar 15. Review.

PMID:
30877381
14.

PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory.

Vigliar E, Malapelle U, Iaccarino A, Acanfora G, Pisapia P, Clery E, De Luca C, Bellevicine C, Troncone G.

J Clin Pathol. 2019 Jun;72(6):412-417. doi: 10.1136/jclinpath-2019-205732. Epub 2019 Mar 7.

PMID:
30846480
15.

BRAF Mutations in Lung Cancer.

Pisapia P, Pepe F, Malapelle U, Troncone G.

Acta Cytol. 2019;63(3):247-250. doi: 10.1159/000496478. Epub 2019 Mar 6. No abstract available.

PMID:
30840950
16.

Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture.

Pallante P, Pisapia P, Bellevicine C, Malapelle U, Troncone G.

Acta Cytol. 2019;63(3):171-181. doi: 10.1159/000496213. Epub 2019 Feb 13. Review.

17.

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer.

Capalbo C, Belardinilli F, Raimondo D, Milanetti E, Malapelle U, Pisapia P, Magri V, Prete A, Pecorari S, Colella M, Coppa A, Bonfiglio C, Nicolussi A, Valentini V, Tessitore A, Cardinali B, Petroni M, Infante P, Santoni M, Filetti M, Colicchia V, Paci P, Mezi S, Longo F, Cortesi E, Marchetti P, Troncone G, Bellavia D, Canettieri G, Giannini G.

Cancers (Basel). 2019 Jan 27;11(2). pii: E147. doi: 10.3390/cancers11020147.

18.

Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature.

Pontieri G, Urselli F, Peschi L, Liccardi A, Ruggiero AR, Vergara E, Bellevicine C, Troncone G, De Palma M, Biondi B.

Front Endocrinol (Lausanne). 2018 Dec 13;9:750. doi: 10.3389/fendo.2018.00750. eCollection 2018.

19.

Liquid Biopsy and Lung Cancer.

Pisapia P, Malapelle U, Troncone G.

Acta Cytol. 2019;63(6):489-496. doi: 10.1159/000492710. Epub 2018 Dec 19. Review.

PMID:
30566947
20.

Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study.

Scimia M, Du J, Pepe F, Bianco MA, Russo Spena S, Patell-Socha F, Sun Q, Powell MJ, Malapelle U, Troncone G.

J Clin Pathol. 2018 Dec;71(12):1123-1126. doi: 10.1136/jclinpath-2018-205412. Epub 2018 Oct 12.

PMID:
30315134
21.

Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients.

Capo A, Sepe R, Pellino G, Milone M, Malapelle U, Pellecchia S, Pepe F, Cacciola NA, Manigrasso M, Bruzzaniti S, Sciaudone G, De Palma GD, Galgani M, Selvaggi F, Troncone G, Fusco A, D'Auria S, Pallante P.

Nanomedicine. 2019 Jan;15(1):231-242. doi: 10.1016/j.nano.2018.09.011. Epub 2018 Oct 9.

PMID:
30308301
22.

The cytopathologist's expanding role in the 2018 updated molecular testing guidelines for lung cancer.

Bellevicine C, Troncone G.

Cancer Cytopathol. 2018 Sep;126(9):753-755. doi: 10.1002/cncy.22060. Epub 2018 Oct 6. No abstract available.

23.

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples.

Pepe F, De Luca C, Smeraglio R, Pisapia P, Sgariglia R, Nacchio M, Russo M, Serra N, Rocco D, Battiloro C, Ambrosio F, Gragnano G, Vigliar E, Bellevicine C, Troncone G, Malapelle U.

J Clin Pathol. 2019 Jan;72(1):38-45. doi: 10.1136/jclinpath-2018-205386. Epub 2018 Oct 2.

PMID:
30279174
24.

Predictive markers in lung cancer: a few hints for the practicing pathologist.

Barbareschi M, Barberis M, Buttitta F, Doglioni C, Fiorentino M, Fontanini G, Franco R, Marchetti A, Rossi G, Troncone G.

Pathologica. 2018 Mar;110(1):29-38. Review.

PMID:
30259911
25.

Potential involvement of neutrophils in human thyroid cancer.

Galdiero MR, Varricchi G, Loffredo S, Bellevicine C, Lansione T, Ferrara AL, Iannone R, di Somma S, Borriello F, Clery E, Triassi M, Troncone G, Marone G.

PLoS One. 2018 Jun 28;13(6):e0199740. doi: 10.1371/journal.pone.0199740. eCollection 2018.

26.

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day.

Uguen A, Troncone G.

J Clin Pathol. 2018 Sep;71(9):757-762. doi: 10.1136/jclinpath-2018-205189. Epub 2018 Jun 14. Review. No abstract available.

PMID:
29903742
27.

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.

Bruera G, Pepe F, Malapelle U, Pisapia P, Mas AD, Di Giacomo D, Calvisi G, Troncone G, Ricevuto E.

Oncotarget. 2018 May 29;9(41):26279-26290. doi: 10.18632/oncotarget.25180. eCollection 2018 May 29.

28.

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.

De Luca C, Rappa AG, Gragnano G, Malapelle U, Troncone G, Barberis M.

J Clin Pathol. 2018 Aug;71(8):745-750. doi: 10.1136/jclinpath-2018-205197. Epub 2018 May 24.

PMID:
29798838
29.

Cytological preparations for molecular analysis: A review of technical procedures, advantages and limitations for referring samples for testing.

da Cunha Santos G, Saieg MA, Troncone G, Zeppa P.

Cytopathology. 2018 Apr;29(2):125-132. doi: 10.1111/cyt.12534. Review.

PMID:
29575423
30.

Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models.

Della Corte CM, Ciaramella V, Cardone C, La Monica S, Alfieri R, Petronini PG, Malapelle U, Vigliar E, Pepe F, Troncone G, Castellone MD, Troiani T, Martinelli E, Ciardiello F, Morgillo F.

J Thorac Oncol. 2018 Jun;13(6):810-820. doi: 10.1016/j.jtho.2018.02.025. Epub 2018 Mar 8.

31.

Key Issues in Molecular Cytopathology.

Troncone G, Roy-Chowdhuri S.

Arch Pathol Lab Med. 2018 Mar;142(3):289-290. doi: 10.5858/arpa.2017-0477-ED. No abstract available.

PMID:
29494222
32.

Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.

Bellevicine C, Sgariglia R, Migliatico I, Vigliar E, D'Anna M, Nacchio MA, Serra N, Malapelle U, Bongiovanni M, Troncone G.

Cancer Cytopathol. 2018 May;126(5):317-325. doi: 10.1002/cncy.21984. Epub 2018 Feb 22.

33.

All-in-one: The dream and reality of molecular cytopathology testing on routine lung cancer smears.

Troncone G.

Cancer Cytopathol. 2018 Mar;126(3):155-157. doi: 10.1002/cncy.21962. Epub 2018 Jan 24. No abstract available.

34.

The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?

Troncone G, Gridelli C.

Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S74-S77. doi: 10.21037/tlcr.2017.10.05. No abstract available.

35.

Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting.

Pisapia P, Pepe F, Smeraglio R, Russo M, Rocco D, Sgariglia R, Nacchio M, De Luca C, Vigliar E, Bellevicine C, Troncone G, Malapelle U.

J Thorac Dis. 2017 Oct;9(Suppl 13):S1383-S1390. doi: 10.21037/jtd.2017.06.97.

36.

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.

Mayo-de-Las-Casas C, Garzón Ibáñez M, Jordana-Ariza N, García-Peláez B, Balada-Bel A, Villatoro S, Malapelle U, Karachaliou N, Troncone G, Rosell R, Molina-Vila MA.

Expert Rev Mol Diagn. 2018 Jan;18(1):35-45. doi: 10.1080/14737159.2018.1407243. Epub 2017 Nov 26. Review.

PMID:
29172773
37.

Reply to Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.

Troncone G.

Cancer Cytopathol. 2017 Nov;125(11):877. doi: 10.1002/cncy.21918. Epub 2017 Sep 11. No abstract available.

38.

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.

Mauro CD, Pesapane A, Formisano L, Rosa R, D'Amato V, Ciciola P, Servetto A, Marciano R, Orsini RC, Monteleone F, Zambrano N, Fontanini G, Servadio A, Pignataro G, Grumetto L, Lavecchia A, Bruzzese D, Iaccarino A, Troncone G, Veneziani BM, Montuori N, Placido S, Bianco R.

Sci Rep. 2017 Aug 24;7(1):9388. doi: 10.1038/s41598-017-10062-1.

39.

Letter to the Editor.

Vigliar E, Bellevicine C, Troncone G.

Clin Lung Cancer. 2018 Jan;19(1):e149. doi: 10.1016/j.cllc.2017.06.012. Epub 2017 Jul 6. No abstract available.

PMID:
28743419
40.

ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.

Pisapia P, Lozano MD, Vigliar E, Bellevicine C, Pepe F, Malapelle U, Troncone G.

Cancer Cytopathol. 2017 Nov;125(11):817-830. doi: 10.1002/cncy.21899. Epub 2017 Jul 25. Review.

41.

How to prepare cytological samples for molecular testing.

Bellevicine C, Malapelle U, Vigliar E, Pisapia P, Vita G, Troncone G.

J Clin Pathol. 2017 Oct;70(10):819-826. doi: 10.1136/jclinpath-2017-204561. Epub 2017 Jul 24. Review.

PMID:
28739858
42.

Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.

Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F.

Br J Haematol. 2018 Sep;182(5):715-718. doi: 10.1111/bjh.14856. Epub 2017 Jul 24. No abstract available.

PMID:
28737231
43.

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Gridelli C, Ardizzoni A, Barberis M, Cappuzzo F, Casaluce F, Danesi R, Troncone G, De Marinis F.

Transl Lung Cancer Res. 2017 Jun;6(3):373-386. doi: 10.21037/tlcr.2017.05.09. Review.

44.

Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.

Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A.

Endocr Relat Cancer. 2017 Sep;24(9):485-493. doi: 10.1530/ERC-17-0085. Epub 2017 Jul 10.

PMID:
28696209
45.

Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology?

De Stefano A, Rosanova M, Malapelle U, Martini M, De Falco S, Attademo L, Fiore G, Cenci T, Bellevicine C, De Placido S, Troncone G, Carlomagno C.

Int J Biol Markers. 2017 Oct 31;32(4):e474-e477. doi: 10.5301/ijbm.5000273.

PMID:
28665451
46.

Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.

Bellelli R, Vitagliano D, Federico G, Marotta P, Tamburrino A, Salerno P, Paciello O, Papparella S, Knauf JA, Fagin JA, Refetoff S, Troncone G, Santoro M.

Mol Cell Endocrinol. 2018 Jan 15;460:24-35. doi: 10.1016/j.mce.2017.06.023. Epub 2017 Jun 23.

47.

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Jain D, Allen TC, Aisner DL, Beasley MB, Cagle PT, Capelozzi VL, Hariri LP, Lantuejoul S, Miller R, Mino-Kenudson M, Monaco SE, Moreira A, Raparia K, Rekhtman N, Roden AC, Roy-Chowdhuri S, da Cunha Santos G, Thunnissen E, Troncone G, Vivero M.

Arch Pathol Lab Med. 2018 Feb;142(2):253-262. doi: 10.5858/arpa.2017-0114-SA. Epub 2017 Jun 22. Review.

PMID:
28639854
48.

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2017 Aug;125(8):615-626. doi: 10.1002/cncy.21868. Epub 2017 May 5.

49.

Intra-institutional second opinion diagnosis can reduce unnecessary surgery for indeterminate thyroid FNA: A preliminary report on 34 cases.

Bellevicine C, Migliatico I, Vigliar E, Serra N, Troncone G.

Cytopathology. 2017 Aug;28(4):254-258. doi: 10.1111/cyt.12431. Epub 2017 May 3.

PMID:
28470780
50.

Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR.

Della Corte CM, Malapelle U, Vigliar E, Pepe F, Troncone G, Ciaramella V, Troiani T, Martinelli E, Belli V, Ciardiello F, Morgillo F.

Oncotarget. 2017 Apr 4;8(14):23020-23032. doi: 10.18632/oncotarget.15479.

Supplemental Content

Loading ...
Support Center